World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
31593
World Ranking
1157
National Ranking
101

Medicine

D-Index
89
Citations
32031
World Ranking
12600
National Ranking
1190

Overview

Mark T. Drayson is affiliated with the University of Birmingham in the United Kingdom. Their research primarily spans the field of medicine, with significant contributions in hematology, molecular biology, infectious diseases, oncology, and immunology.

The scientist's work covers several focused topics, including:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Treatment and Pharmacology
  • Peptidase Inhibition and Analysis
  • COVID-19 Clinical Research Studies
  • Immunotherapy and Immune Responses

Some of the frequent co-authors with whom Mark T. Drayson has collaborated include:

  • Gordon Cook
  • Roger G. Owen
  • Martin Kaiser
  • Graham Jackson
  • David A. Cairns

The scientist has published in several prominent academic venues, with a strong presence in:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Lymphoma Myeloma & Leukemia
  • British Journal of Haematology
  • Blood Cancer Journal

Key recent papers authored or co-authored by Mark T. Drayson include:

  • SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study (2020, Thorax)
  • Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples (2020, Emerging infectious diseases)
  • Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma (2023, Journal of Clinical Oncology)
  • Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials (2020, Blood)
  • Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection (2020, bioRxiv [Cold Spring Harbor Laboratory])

This body of work reflects a focus on infectious diseases, particularly COVID-19, as well as hematological malignancies and their treatment protocols. The contribution to multiple myeloma research is notable with studies addressing both clinical outcomes and pharmacological interventions.

Best Publications

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

    J. Anthony Child;Gareth J. Morgan;Faith E. Davies;Roger G. Owen

  • Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset.

    David A Somerset;Yong Zheng;Mark D Kilby;David M Sansom

  • Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine

    Arthur R. Bradwell;Hugh D. Carr-Smith;Graham P. Mead;Lian X. Tang

  • First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

    Gareth J Morgan;Faith E Davies;Walter M Gregory;Kim Cocks

  • Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

    Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison

  • Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party

    Bradley M. Augustson;Gulnaz Begum;Janet A. Dunn;Nicola J. Barth

  • Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

    Mark Drayson;Lian X. Tang;Roger Drew;Graham P. Mead

  • Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

    C A Bradbury;F L Khanim;R Hayden;C M Bunce

  • Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

    Andy C. Rawstron;J. Anthony Child;Ruth M. de Tute;Faith E. Davies

  • The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

    Gareth J. Morgan;Walter M. Gregory;Faith E. Davies;Sue E. Bell

  • A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

    E. V. McCloskey;I. C. M. Maclennan;M. T. Drayson;C. Chapman

  • Serum test for assessment of patients with Bence Jones myeloma

    Arthur R Bradwell;Hugh D Carr-Smith;Graham P Mead;Timothy C Harvey

  • How I treat monoclonal gammopathy of renal significance (MGRS)

    Jean Paul Fermand;Frank Bridoux;Robert A. Kyle;Efstathios Kastritis

  • Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.

    Graham H Jackson;Faith E Davies;Charlotte Pawlyn;Charlotte Pawlyn;David A Cairns

  • APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

    Brian A Walker;Christopher P Wardell;Alex Murison;Eileen M Boyle

  • The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children

    Calman A. MacLennan;Esther N. Gondwe;Chisomo L. Msefula;Robert A. Kingsley

  • Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial

    Joanna E. Long;Mark T. Drayson;Angela E. Taylor;Kai M. Toellner

  • Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

    Andy C. Rawstron;Andy C. Rawstron;Andy C. Rawstron;Faith E. Davies;Faith E. Davies;Faith E. Davies;Ranjit DasGupta;Ranjit DasGupta;Ranjit DasGupta;A. John Ashcroft;A. John Ashcroft;A. John Ashcroft

  • Serum free light chains for monitoring multiple myeloma.

    G. P. Mead;H. D. Carr-Smith;M. T. Drayson;G. J. Morgan

  • SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.

    Adrian Shields;Adrian Shields;Sian E Faustini;Marisol Perez-Toledo;Sian Jossi

  • Apobec Family Mutational Signatures Are Associated with Poor Prognosis Translocations in Multiple Myeloma

    Brian A Walker;Brian A Walker;Christopher P Wardell;Alexander Murison;Eileen M Boyle

Frequent Co-Authors

Gareth J. Morgan
Gareth J. Morgan Boston University
Faith E. Davies
Faith E. Davies New York University Langone Medical Center
Graham Jackson
Graham Jackson University of Newcastle Australia
Walter M Gregory
Walter M Gregory University of Leeds
Jos A. Bosch
Jos A. Bosch University of Amsterdam
Nigel H. Russell
Nigel H. Russell University of Nottingham
Douglas Carroll
Douglas Carroll University of Birmingham
Christopher Ring
Christopher Ring University of Birmingham
Brian A Walker
Brian A Walker Indiana University – Purdue University Indianapolis
Calman A. MacLennan
Calman A. MacLennan Bill & Melinda Gates Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related online degree programs can open doors to diverse healthcare careers. Many students transition into advanced nursing roles that complement their immunological knowledge. For example, acnp programs help Family Nurse Practitioners specialize in acute care settings, combining clinical expertise with a deep understanding of immune system responses.

Accelerated options such as the nurse practitioner accelerated program allow students to fast-track their education and enter the healthcare workforce efficiently. These programs are particularly beneficial for those seeking to integrate immunology into patient care roles quickly.

For newcomers to nursing, online pathways like online rn programs for non nurses in florida provide accessible entry points into the profession. These programs offer foundational clinical and scientific knowledge, including elements relevant to immunology.

Additionally, students aiming for a Bachelor of Science in Nursing with a smooth admission process may consider the easiest absn to get into. This pathway supports rapid advancement while building expertise that can intersect with immunological research and practice.

Best Scientists Citing Mark T. Drayson

Trending Scientists

Recently Published Articles